Ernexa Therapeutics Inc.ERNANASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR+136.4%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
+136.4%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
73.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 75.41% |
| Q2 2025 | -306.67% |
| Q1 2025 | 64.29% |
| Q4 2024 | 91.46% |
| Q3 2024 | -382.35% |
| Q2 2024 | 17.07% |
| Q1 2024 | -7.89% |
| Q4 2023 | -10.68% |
| Q3 2023 | -21.18% |
| Q2 2023 | 19.81% |
| Q1 2023 | -3.92% |
| Q4 2022 | 59.04% |
| Q3 2022 | -203.32% |
| Q2 2022 | 151.83% |
| Q1 2022 | -43.08% |
| Q4 2021 | 90.46% |
| Q3 2021 | -616.84% |
| Q2 2021 | 62.72% |
| Q1 2021 | -696.25% |
| Q4 2020 | -64.95% |
| Q3 2020 | 1.02% |
| Q2 2020 | -100.00% |
| Q1 2020 | 0.00% |